These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 18573540
1. Personality disorders and perceived stress in major depressive disorder. Candrian M, Schwartz F, Farabaugh A, Perlis RH, Ehlert U, Fava M. Psychiatry Res; 2008 Aug 15; 160(2):184-91. PubMed ID: 18573540 [Abstract] [Full Text] [Related]
2. Perceived stress and cognitive vulnerability mediate the effects of personality disorder comorbidity on treatment outcome in major depressive disorder: a path analysis study. Candrian M, Farabaugh A, Pizzagalli DA, Baer L, Fava M. J Nerv Ment Dis; 2007 Sep 15; 195(9):729-37. PubMed ID: 17984772 [Abstract] [Full Text] [Related]
3. Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study. Grilo CM, Stout RL, Markowitz JC, Sanislow CA, Ansell EB, Skodol AE, Bender DS, Pinto A, Shea MT, Yen S, Gunderson JG, Morey LC, Hopwood CJ, McGlashan TH. J Clin Psychiatry; 2010 Dec 15; 71(12):1629-35. PubMed ID: 20584514 [Abstract] [Full Text] [Related]
4. Problem-solving ability and comorbid personality disorders in depressed outpatients. Harley R, Petersen T, Scalia M, Papakostas GI, Farabaugh A, Fava M. Depress Anxiety; 2006 Dec 15; 23(8):496-501. PubMed ID: 16845662 [Abstract] [Full Text] [Related]
6. Relationships between major depressive disorder and comorbid anxiety and personality disorders. Farabaugh A, Fava M, Mischoulon D, Sklarsky K, Petersen T, Alpert J. Compr Psychiatry; 2005 Dec 15; 46(4):266-71. PubMed ID: 16175757 [Abstract] [Full Text] [Related]
7. Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset. Ongur D, Farabaugh A, Iosifescu DV, Perlis R, Fava M. Psychother Psychosom; 2005 Dec 15; 74(3):173-8. PubMed ID: 15832068 [Abstract] [Full Text] [Related]
8. Personality disorders and the trimensional personality questionnaire factors in major depressive disorder. Farabaugh A, Ongur D, Fava M, Hamill SK, Burns AM, Alpert J. J Nerv Ment Dis; 2005 Nov 15; 193(11):747-50. PubMed ID: 16260931 [Abstract] [Full Text] [Related]
9. Personality disorder comorbidity with major depression and response to fluoxetine treatment. Fava M, Bouffides E, Pava JA, McCarthy MK, Steingard RJ, Rosenbaum JF. Psychother Psychosom; 1994 Nov 15; 62(3-4):160-7. PubMed ID: 7846259 [Abstract] [Full Text] [Related]
10. Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study. Melartin TK, Haukka J, Rytsälä HJ, Jylhä PJ, Isometsä ET. J Clin Psychiatry; 2010 Mar 15; 71(3):287-95. PubMed ID: 20079331 [Abstract] [Full Text] [Related]
15. Relationships of neuroticism and extraversion with axis I and II comorbidity among patients with DSM-IV major depressive disorder. Jylhä P, Melartin T, Isometsä E. J Affect Disord; 2009 Apr 15; 114(1-3):110-21. PubMed ID: 18687471 [Abstract] [Full Text] [Related]
16. Six months of treatment for depression: outcome and predictors of the course of illness. Mulder RT, Joyce PR, Frampton CM, Luty SE, Sullivan PF. Am J Psychiatry; 2006 Jan 15; 163(1):95-100. PubMed ID: 16390895 [Abstract] [Full Text] [Related]
17. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population. Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ. Depress Anxiety; 2008 Jan 15; 25(1):46-54. PubMed ID: 17149753 [Abstract] [Full Text] [Related]
18. Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine. Denninger JW, Papakostas GI, Mahal Y, Merens W, Alpert JE, Nierenberg AA, Yeung A, Fava M. Psychosomatics; 2006 Jan 15; 47(4):348-52. PubMed ID: 16844895 [Abstract] [Full Text] [Related]
19. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue. Ninan PT, Hassman HA, Glass SJ, McManus FC. J Clin Psychiatry; 2004 Mar 15; 65(3):414-20. PubMed ID: 15096082 [Abstract] [Full Text] [Related]
20. The predictive validity of Cluster C personality disorders on the persistence of major depression in the national epidemiologic survey on alcohol and related conditions. Oleski J, Cox BJ, Robinson J, Grant B. J Pers Disord; 2012 Jun 15; 26(3):322-33. PubMed ID: 22686221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]